CJ
DGX icon

Caitlin John’s Quest Diagnostics DGX Stock Holding History

Caitlin John’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$640 Hold
3
– – ﹤0.01% 836
2025
Q4 		$564 Hold
3
– – ﹤0.01% 846
2025
Q3 		$617 Buy
+3
New +$532 ﹤0.01% 811
2025
Q1 		– Sell
-3
Closed -$481 – 284
2024
Q4 		$481 Hold
3
– – ﹤0.01% 788
2024
Q3 		$512 Hold
3
– – ﹤0.01% 780
2024
Q2 		$432 Sell
3
-2
-40% -$274 ﹤0.01% 780
2024
Q1 		$687 Sell
5
-2
-29% -$259 ﹤0.01% 783
2023
Q4 		$984 Buy
+7
New +$920 ﹤0.01% 758

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Caitlin John's DGX Position: Q1 2026 in Review

Caitlin John held its Quest Diagnostics (DGX) position steady in Q1 2026 at 3 shares worth $640. The position accounts for ﹤0.01% of the portfolio, ranked #836.

Caitlin John first reported a position in DGX in Q4 2023 and has held it in 8 quarters since. The position peaked at $984 in Q4 2023. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Caitlin John held 3 shares of Quest Diagnostics worth $640 as of Q1 2026.
  • Caitlin John left its Quest Diagnostics share count unchanged in Q1 2026.
  • Quest Diagnostics made up ﹤0.01% of Caitlin John's portfolio in Q1 2026, its #836 holding.
  • Caitlin John first reported a position in Quest Diagnostics in Q4 2023 and has held it in 8 quarters since.
  • Caitlin John's Quest Diagnostics position peaked at $984 in Q4 2023.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Caitlin John's 13F filing for Q1 2026, filed 13 May 2026.